Sanjay S. Shukla
2017
In 2017, Sanjay S. Shukla earned a total compensation of $2.2M as President and CEO at aTYR PHARMA, a 97% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $131,625 |
|---|---|
| Option Awards | $1,620,279 |
| Salary | $402,813 |
| Other | $9,840 |
| Total | $2,164,557 |
Shukla received $1.6M in option awards, accounting for 75% of the total pay in 2017.
Shukla also received $131.6K in non-equity incentive plan, $402.8K in salary and $9.8K in other compensation.
Rankings
In 2017, Sanjay S. Shukla's compensation ranked 5,137th out of 14,666 executives tracked by ExecPay. In other words, Shukla earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,137 out of 14,666 | 65th |
Division Manufacturing | 1,828 out of 5,772 | 68th |
Major group Chemicals And Allied Products | 544 out of 2,075 | 74th |
Industry group Drugs | 419 out of 1,731 | 76th |
Industry Biological Products, Except Diagnostic Substances | 77 out of 313 | 75th |
Source: SEC filing on April 3, 2018.
Shukla's colleagues
We found three more compensation records of executives who worked with Sanjay S. Shukla at aTYR PHARMA in 2017.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019